Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Azonafide derived tumor and cancer targeting compounds

Azonafide derived tumor and cancer targeting compounds

US Patent 8008316 · Granted Aug 30, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

K-Ras modulators2022
Peptide inhibition of CCR3-mediated diseases or conditions2021
Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial2019
Peptide inhibition of CCR3-mediated diseases or conditions2019
Peptide-based stat inhibitor2017
Peptide-based stat inhibitor2017
Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling2016
Self-assembling nanoparticles composed of transmembrane peptides and their appli2016
Self-assembling nanoparticles composed of transmembrane peptides and their appli2016
Lipopeptide inhibitors of RAS oncoproteins2016
Antiproliferative factor and methods of use2015
Derivatives of APF and methods of use2015